Evidence map›Paper›PMID 42776255›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026

Pupillometric alterations in Graves' disease: Beyond thyroid functional status.

Umay Güvenç, Gülizar Soyugelen, Dudu Deniz Açar, Menekşe İnal Özen, Gönül Koç, Elif Gökçen Acar, Ayşe Burcu

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Umay GüvençDepartment of Ophthalmology, Ankara Training and Research Hospital, Ankara, 06230, Türkiye. umay.guvenc@gmail.com.
Gülizar SoyugelenDepartment of Ophthalmology, Ankara Training and Research Hospital, Ankara, 06230, Türkiye.
Dudu Deniz AçarDepartment of Ophthalmology, Ankara Training and Research Hospital, Ankara, 06230, Türkiye.
Menekşe İnal ÖzenDepartment of Ophthalmology, Kastamonu Training and Research Hospital, Kastamonu, Türkiye.
Gönül KoçDepartment of Endocrinology and Metabolism, Ankara Training and Research Hospital, Ankara, Türkiye.
Elif Gökçen AcarDepartment of Ophthalmology, Ankara Training and Research Hospital, Ankara, 06230, Türkiye.
Ayşe BurcuDepartment of Ophthalmology, Ankara Training and Research Hospital, Ankara, 06230, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate static and dynamic pupillometric parameters in patients with Graves' disease (GD) compared with healthy controls, and to examine their relationships with thyroid functional status, thyroid hormone levels, clinical activity, thyrotropin receptor antibody (TRAb) levels, and orbitopathy.

methodsIn this prospective cross-sectional study, 51 patients with GD and 45 healthy controls underwent automated pupillometry. Static pupil diameters were measured under scotopic, mesopic, and photopic conditions, and mean pupil dilation speed (MPDS) was assessed during redilation. Associations with clinical and biochemical variables were assessed using Spearman correlation with Benjamini-Hochberg correction and multiple linear regression. Significant group differences were further assessed using age- and sex-adjusted analysis of covariance, and thyroid hormone-pupillometry correlations were compared between groups using Fisher's r-to-z transformation.

resultsCompared with controls, patients with GD exhibited larger mesopic (p = 0.032) and photopic (p = 0.021) pupil diameters and lower MPDS (p = 0.034), with differences remaining significant after age and sex adjustment. Among patients with GD, no statistically significant differences in pupillometric parameters were detected between euthyroid and hyperthyroid patients or according to orbitopathy status (all p > 0.05). Clinical Activity Score (CAS) correlated with scotopic (ρ = 0.498, p < 0.001) and mesopic pupil diameters (ρ = 0.442, p = 0.006) and inversely with MPDS (ρ=-0.561, p < 0.001); TRAb correlated with mesopic (ρ = 0.431, p = 0.006) and photopic pupil diameters (ρ = 0.502, p = 0.001) and inversely with MPDS (ρ=-0.538, p = 0.001). Continuous free triiodothyronine (fT3) correlated with all static pupil diameters and MPDS in GD, most strongly with mesopic pupil diameter (ρ = 0.598, p < 0.001). Between-group comparisons confirmed stronger fT3 correlations with scotopic (p = 0.047) and mesopic (p = 0.023) pupil diameters in GD than in controls. Multivariable analyses identified CAS as an independent predictor of scotopic pupil diameter (p = 0.006) and MPDS (p = 0.028), TRAb of photopic pupil diameter (p = 0.001), and fT3 of mesopic pupil diameter (p = 0.010). Age independently predicted scotopic (p < 0.001), photopic pupil diameter (p = 0.016), and MPDS (p = 0.003).

conclusionIn this study of patients with GD, no statistically significant differences in pupillometric parameters were detected according to categorical thyroid functional status or orbitopathy status. However, fT3 independently predicted mesopic pupil diameter, while CAS and TRAb demonstrated independent, parameter-specific associations with static and dynamic pupillometric measures. As comparable hormone-pupillometry associations were not demonstrated in healthy controls, pupillometric alterations in GD may reflect disease-related clinical and biochemical influences beyond categorical thyroid status alone.

Indexed as

Clinical Activity ScoreGraves’ DiseaseGraves’ OrbitopathyPupillometryThyroid HormonesThyrotropin Receptor Antibodies

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.